DLB
Dolby Laboratories
57.50$
-2.2%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1,539.1% | +5.7% | +5.4% | -2.5% | +17.7% | -6.4% | +10.3% | -2.1% | -19.5% | +26.2% | +5.9% | |
| – | +35.1% | +14.9% | +8.6% | +7.8% | +26.1% | -8.9% | -11.2% | +8.7% | -17.2% | +20.1% | +14.0% | |
| – | -1.6% | +4.7% | +5.1% | -3.7% | +16.6% | -6.1% | +13.4% | -3.4% | -19.8% | +27.0% | +4.9% | |
| – | +9.9% | +9.1% | +6.2% | +1.5% | +0.5% | +0.5% | +6.1% | +3.0% | -23.0% | +31.1% | -0.7% | |
| – | – | -7.3% | +1.7% | +15.0% | +4.1% | +7.0% | +2.0% | +22.8% | -30.3% | +40.9% | +6.0% | |
| – | – | +3.2% | +2.6% | +6.0% | +5.8% | +1.0% | +2.0% | +10.5% | -26.7% | +32.3% | +6.4% | |
| – | -22.0% | +9.1% | +12.2% | -30.0% | +60.4% | -24.9% | +54.5% | -36.3% | +0.9% | +20.7% | +0.1% | |
| – | – | -31.7% | +1.6% | +55.9% | -14.1% | +9.4% | +157.5% | -17.7% | -59.1% | +21,065.8% | – | |
| – | – | -4.0% | +8.8% | -23.5% | +43.8% | -15.1% | +47.9% | -39.3% | +12.0% | +29.6% | -2.9% | |
| – | -7.2% | -20.8% | +9.5% | +184.2% | -82.6% | -69.8% | +353.2% | -14.5% | -257.1% | – | -2.4% | |
| – | -12.0% | +2.5% | +8.6% | -79.3% | +511.2% | -9.3% | +34.1% | -40.7% | +4.0% | +36.7% | -2.6% | |
| – | – | +2.0% | +6.2% | -18.6% | +32.3% | -10.0% | +36.2% | -29.2% | -31.2% | +82.4% | -5.3% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.